We are live on
!
Find out more
C
Consulta Portfolio holdings
AUM
$2.77B
1-Year Est. Return
3.62%
This Fund
S&P 500
This Quarter
Est. Return
-0.82%
1 Year Est. Return
+3.62%
3 Year Est. Return
+30.69%
5 Year Est. Return
+30.14%
10 Year Est. Return
+206.35%
AUM
$764M
AUM Growth
-$183M
(-19%)
Cap. Flow
-$146M
Cap. Flow
% of AUM
-19.09%
Top 10 Holdings %
Top 10 Hldgs %
90.76%
Holding
16
New
3
Increased
2
Reduced
5
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$66.7M |
| 2 |
Comcast
CMCSA
|
+$30.1M |
| 3 |
MON
Monsanto Co
MON
|
+$23.5M |
| 4 |
Visa
V
|
+$20.5M |
| 5 |
HCA Healthcare
HCA
|
+$14M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$81.5M |
| 2 |
JAH
JARDEN CORPORATION
JAH
|
+$55M |
| 3 |
Sensata Technologies
ST
|
+$46M |
| 4 |
American International
AIG
|
+$31.3M |
| 5 |
Bausch Health
BHC
|
+$28.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 25.42% |
| 2 | Communication Services | 17.47% |
| 3 | Financials | 15.65% |
| 4 | Real Estate | 13.33% |
| 5 | Consumer Discretionary | 11.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Charter Communications
CHTR
$18.2B
| $105M | 13.78% |
575,000
-75,000
| -12% | -$13.9M |
|
2
Howard Hughes
HHH
$4.07B
| $102M | 13.33% |
944,100
| – | – |
|
|
3
Berkshire Hathaway Class B
BRK.B
$1.07T
| $99M | 12.96% |
750,000
+496,940
| +196% | +$66.7M |
|
4
Allison Transmission
ALSN
$10.3B
| $84.1M | 11.01% |
3,250,000
| – | – |
|
|
5
HCA Healthcare
HCA
$88.1B
| $81.2M | 10.62% |
1,200,000
+200,000
| +20% | +$14M |
|
|
6
Sensata Technologies
ST
$6.22B
| $80.6M | 10.55% |
1,750,000
-1,000,000
| -36% | -$46M |
|
7
DaVita
DVA
$11.3B
| $52.3M | 6.84% |
750,000
| – | – |
|
8
Thermo Fisher Scientific
TMO
$227B
| $35.5M | 4.64% |
250,000
-200,000
| -44% | -$26.7M |
|
|
9
Comcast
CMCSA
$94.4B
| $28.2M | 3.69% |
+1,000,000
| New | +$30.1M |
|
10
Element Solutions
ESI
$8.82B
| $25.7M | 3.36% |
2,000,000
-1,500,000
| -43% | -$18.2M |
|
|
11
Bausch Health
BHC
$2.58B
| $25.4M | 3.33% |
250,000
-250,000
| -50% | -$28.1M |
|
|
MON
12
DELISTED
Monsanto Co
MON
| $24.6M | 3.22% |
+250,000
| New | +$23.5M |
|
|
13
Visa
V
$682B
| $20.6M | 2.69% |
+265,000
| New | +$20.5M |
|
|
14
American International
AIG
$39.6B
| – | – |
-550,000
| Closed | -$31.3M |
|
|
AGN
15
DELISTED
Allergan plc
AGN
| – | – |
-300,000
| Closed | -$81.5M |
|
|
JAH
16
DELISTED
JARDEN CORPORATION
JAH
| – | – |
-1,125,000
| Closed | -$55M |
|
Similar funds
HCM
BGM
SIM
JHP
DJSG
CAAS
CCM
FFA
Consulta's Q4 2015 Portfolio in Review
As of Q4 2015, Consulta held 16 positions worth $764M, down 19% from $947M the previous quarter. Its ten largest holdings account for 91% of the portfolio.
Consulta withdrew a net $146M in Q4 2015, closing 3 positions and reducing 5 holdings. Its most notable exit was Allergan plc, an estimated $81.5M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 25% of assets, down from 38% a quarter earlier, followed by Communication Services and Financials.
Against the trend, Consulta opened a new position in Comcast worth $28.2M.
- Consulta's largest Q4 2015 buy was Comcast: 1,000,000 shares worth $28.2M.
- Consulta added most to Berkshire Hathaway Class B in Q4 2015, an estimated $66.7M increase.
- Consulta's biggest Q4 2015 reduction was Sensata Technologies, cutting an estimated $46M.
- Consulta fully exited Allergan plc in Q4 2015, selling an estimated $81.5M.
- Consulta's ten largest holdings make up 91% of its $764M portfolio in Q4 2015.
- Consulta opened 3 new positions and closed 3 in Q4 2015.
- Consulta's portfolio value fell 19% quarter-over-quarter to $764M.
Based on Consulta's 13F filing for Q4 2015, filed 16 Feb 2016.